Formulation development and optimization of controlled porosity osmotic pump tablets of diclofenac sodium

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 3, Issue 1, 2011, Pages 80-87

  Edavalath, Sudeesh ^a   Shivanand, K ^a   Prakasam, Kalyani ^a   Rao, B Prakash ^a   Divakar, Goli ^a  

^a ACHARYA AND B M REDDY COLLEGE OF PHARMACY   (India)

Author keywords

Diclofenac sodium; Optimal optimization; Poly ethylene glycol 400; Porous osmotic pump; Sodium chloride

Indexed keywords

DICLOFENAC; MACROGOL 400; OSMOTIC AGENT; SODIUM CHLORIDE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; FEASIBILITY STUDY; INFRARED SPECTROSCOPY; OSMOSIS; OSMOTIC PUMP; PH; PHYSICAL CHEMISTRY; TABLET POROSITY;

EID: 79251551644     PISSN: 09751491     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chien YW. Novel drug delivery systems. 2nd ed. New York: Marcel Dekker; 2005. p.139-96.
2. Sharma S. Osmotic controlled drug delivery system. [Online]. [2008 Oct 20]; [1]. Available from: URL:http://www.pharmainfo.net/reviews/osmotic-controlleddrug-delivery-system.
3. Makhija SN, Vavia PR. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine I. Cellulose acetate as a semi permeable membrane. J Control Release 2003; 89:5-18.
4. Mehramizi A, Asgari ME, Pourfarzib M, Bayati KH, Dorkoosh FA, Rafiee T M. Influence of β-cyclodextrin complexation on lovastatin release from osmotic pump tablets (OPT). DARU 2007; 15(2):71-8.
5. Sheng-Fang S, Chen-His C, Chao-Feng K, Jin-ding H. In vitro and in vivo comparison of two diclofenac sodium sustained release oral formulations. Int J Pharm 2003; 260:39-46.
6. Chowdary KPR, Mohapatra P, Krishna MN. Evaluation of olibanum and its resin as rate controlling matrix for controlled release of diclofenac. Indian J Pharm Sci 2006; 68(4):497-500.
7. James S. Encyclopedia of pharmaceutical technology. 3rd ed. New York: Informa healthcare; 2007, p.2452-66.
8. Punna RR, Sindhura G, Ranendra NS. Design and study of lamivudine oral controlled release tablets. AAPS Pharm Sci Tech 2007; 8(4):E1-E9.
9. Kanagale P, Lohray BB, Misra A, Davadra P, Kini R. Formulation and optimization of porous osmotic pumpbased controlled release system of oxybutynin. AAPS Pharm Sci Tech 2007; 8(3):E1-E7.
10. Wen-Jen L, Hong-Guann L. Design of a microporous controlled delivery system for theophylline tablets. J Control Release 2003; 89:179-87.
11. Hamdy A, Ossama Y A, Hesham S. Formulation of controlled release baclofen matrix tablets: Influence of some hydrophilic polymers on the release rate and in vitro evaluation. AAPS Pharm Sci Tech 2007; 8(4):E1-E11.
12. Ayhan S, Yalcin O, Askin I̧ Imer. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium. Farmaco 2005; 60:171-77.
13. Donald LW. Hand book of Pharmaceutical Controlled Release Technology. New York: Marcel Dekker; 2000, p.183-8, 225-54, 431-6.
14. Prakash RB, Geetha M, Purushothama N, Utpal S. Optimization and development of swellable controlled porosity osmotic pump tablet for theophylline. Trop J Pharm Research 2009; 8(3):247-55.